Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
. The position is available from 1 February 2026. The initial contract will be for one year. For more information on research in the Hondele lab see: https://www.biozentrum.unibas.ch/research/research
-
at adam.altenhof@eaps.ethz.ch and/or Dr. Xiang-Zhao Kong at xkong@ethz.ch . About ETH Zürich ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our
-
of pathology and oncology. In-depth expertise in tumor biology – particularly in the study of tumor heterogeneity, resistance mechanisms, and cellular plasticity – is required. The position further requires
-
3 Jan 2026 Job Information Organisation/Company University of Basel Research Field Agricultural sciences » Soil science Agricultural sciences » Other Environmental science » Earth science
-
20 Dec 2025 Job Information Organisation/Company University of Basel Research Field Biological sciences » Biology Biological sciences » Other Engineering » Other Medical sciences » Other Technology
-
19 Dec 2025 Job Information Organisation/Company University of Basel Research Field Agricultural sciences » Forest sciences Agricultural sciences » Soil science Agricultural sciences » Other
-
6 Jan 2026 Job Information Organisation/Company ETH Zürich Research Field Agricultural sciences » Forest sciences Chemistry » Biochemistry Environmental science » Earth science Environmental science
-
28 Dec 2025 Job Information Organisation/Company ETH Zürich Research Field Biological sciences » Other Computer science » Programming Engineering » Other Medical sciences » Other Technology
-
cellular biology. The position is available from 1 February 2026. The initial contract will be for one year. For more information on research in the Hondele lab see: https://www.biozentrum.unibas.ch/research
-
Your position High-throughput drug screening has traditionally relied on 2D cell culture systems, which often fail to capture the structural and metabolic complexity of in vivo patient tumors